Replies to post #305570 on Innovation Pharmaceuticals Inc (IPIX)

[Lemoncat]

The key point is Brilacidin really couldn't have performed any better than it did in vitro. It now needs to be moved into the clinic to see how the results translate to human efficacy.

Especially because Brilacidin probably kills viruses by 'popping' their protective membranes, some other antivirals act like viral prophylactics.

Brilacidin appears to do both, no?


Prophylactic:

http://www.ipharminc.com/press-release/2020/5/26/innovation-pharmaceuticals-receives-data-from-public-health-research-institute-showing-brilacidin-inhibits-sars-cov-2-covid-19-in-a-human-cell-line

http://www.ipharminc.com/press-release/2020/5/19/innovation-pharmaceuticals-brilacidin-reduces-viral-titer-of-sars-cov-2-covid-19-by-75-percent-after-only-1-hour-of-preincubation-in-in-vitro-study-at-bsl-3-facility

Viricidal Lung:

http://www.ipharminc.com/press-release/2020/6/17/innovation-pharmaceuticals-brilacidin-inhibits-sars-cov-2-covid-19-by-97-percent-in-a-human-lung-cell-line

Viricidal Kidney:

http://www.ipharminc.com/press-release/2020/4/1/innovation-pharmaceuticals-receives-data-supporting-brilacidins-direct-inhibition-of-sars-cov-2-the-novel-coronavirus-responsible-for-covid-19

Go IPIX!